Cargando…
H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition
BACKGROUND: Adriamycin (ADM) is a drug commonly used for treating gastric cancer (GC). However, chemoresistance presents an obstacle to achieving successful outcomes in patients treated with chemotherapy. This study aimed to explore the effect of long non-coding RNA (lncRNA) H19 on chemoresistance i...
Autores principales: | Jiang, Xiaodong, Ding, Wenbin, Shen, Weiguang, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798114/ https://www.ncbi.nlm.nih.gov/pubmed/35117758 http://dx.doi.org/10.21037/tcr-20-1736 |
Ejemplares similares
-
MEG3/miR-21 axis affects cell mobility by suppressing epithelial-mesenchymal transition in gastric cancer
por: Xu, Gang, et al.
Publicado: (2018) -
Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013) -
CircRNA_0005075 suppresses carcinogenesis via regulating miR‐431/p53/epithelial‐mesenchymal transition axis in gastric cancer
por: Wu, Jiaming, et al.
Publicado: (2020) -
The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer
por: Yu, Wei-Wei, et al.
Publicado: (2017) -
The miR-370/UQCRC2 axis facilitates tumorigenesis by regulating epithelial-mesenchymal transition in Gastric Cancer
por: Wang, Dan-wen, et al.
Publicado: (2020)